© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Dl-Epinephrine, often called Racemic Epinephrine, refers to a synthetic form of adrenaline containing equal parts of the dextro (D-) and levo (L-) isomers. The clinical world uses this compound for its rapid physiological effects, especially in emergency settings. Unlike pure L-epinephrine found in nature, the racemic mixture incorporates both forms, which influences its pharmacological profile, notably in treating respiratory conditions. I remember hearing from a doctor friend who worked in pediatrics that racemic epinephrine often showed up in the ER during croup season, helping kids breathe easier within minutes. Beyond its medical use, its chemical properties and physical form hold significance in several industries.
Examining Dl-Epinephrine, you notice it generally comes as a white or slightly off-white crystalline solid or powder. Its density measures around 1.28 g/mL at 20°C. Its molecular formula is C9H13NO3, with a molecular weight hovering near 183.21 g/mol. Some suppliers offer racemic epinephrine as flakes, while others present it as small solid pearls or a fine crystalline powder, depending on intended use and processing. It dissolves in water, forming a clear solution, an essential trait for reliable dosing in liquid formulations.
Dl-Epinephrine melts between 211°C and 215°C. This melting range allows precise quality control, reducing the chance of batch variability. Handling requires caution because both the powder and any prepared solution can oxidize, taking on a pink or brownish tint if exposed to light or air, signaling reduced potency. From a storage perspective, pharmaceutical-grade racemic epinephrine is kept in airtight, dark glass to limit degradation. Shelf stability depends on strict temperature regulation and minimal moisture exposure; that’s based on regulatory standards grounded in years of product recalls and close calls.
Every batch of racemic epinephrine must adhere to established purity parameters, with impurities strictly capped below 1%. Manufacturers employ high-performance liquid chromatography to identify and quantify both isomers, ensuring the 50:50 ratio. Each molecule’s structure features a catechol group bonded to an ethylamine side-chain, with chirality at the α-carbon. This configuration matters: only the L-form provides strong cardiovascular effects, but the D-form modifies receptor binding, supporting symptom relief in airway inflammation. Common packaging includes single-use ampoules for medical treatment, as well as bulk solid material for chemical applications.
The product falls under HS Code 2939.41.00 for international customs, which helps manage its trade due to strict regional controls. Warehouse records routinely mark temperature and humidity, using lot tracking for rapid recall if any contamination surfaces. Many chemical distributors mark specifications like particle size (often under 100 microns for powders), and solubility figures (over 10 mg/mL in water) to meet end-user requirements. Variability in these physical properties directly impacts how easily the substance integrates into finished pharmaceuticals or laboratory protocols.
Anyone who has needed to prepare or administer racemic epinephrine quickly notices the tight safety protocols. Direct skin contact can trigger irritation; inhalation or accidental injection may provoke cardiovascular symptoms even in healthy adults. Chemical safety data sheets list this material as hazardous, with recommended handling in ventilated environments, full skin coverage, and ready access to eyewash stations. Even trace residues can disrupt heart rhythm in sensitive individuals. It’s no wonder staff in compounding pharmacies double-check each preparation step and disposal guideline. Hazard communication standards classify racemic epinephrine as harmful by ingestion, inhalation, or significant dermal exposure.
Raw material supply traces back to basic aromatic precursors, refined through multi-step organic synthesis. The labor-intensive route requires careful selection of starting material to maintain impurity levels. Global availability relies on regulated facilities, as some of the intermediates count as controlled substances. Transparency in sourcing matters, especially with tightening supply chains and recurring recalls in the pharmaceutical market. Any errors in raw material purity echo through to the final administered dose and could spell big problems in critical care. Strict audit trails and barcode systems help keep companies honest about how and where material moves, safeguarding both patients and employees.
Many practitioners remember hospital shortages, when a missing batch sparked frantic calls to other departments. Lack of access to racemic epinephrine highlighted the need to reformulate or substitute with less optimal alternatives. Improving transparency in global transportation, maintaining buffer stocks, and ramping up secondary suppliers all help cushion these shocks. Watching policymakers and logisticians try to sort out access to this chemical demonstrates the difficulty of balancing safety regulations against real-life emergencies.
